Related Experiment Videos
Social phobia: a pharmacologic treatment overview
1Dean Foundation for Health, Resarch and Education, Madison, Wis. 53717-1914, USA.
The Journal of Clinical Psychiatry
|January 1, 1995
Summary
Pharmacotherapy for social phobia has advanced, with proven efficacy for various medications including MAOIs, SSRIs, and benzodiazepines. Beta-blockers are useful for performance anxiety but not generalized social phobia.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Social phobia is a prevalent, chronic, and disabling mental health condition.
- Recent advancements have significantly improved medication options for social phobia.
Purpose of the Study:
- To review the current pharmacotherapy landscape for generalized and specific social phobias.
- To highlight the efficacy of various drug classes in treating social phobia.
Main Methods:
- Review of controlled studies, case reports, and double-blind trials.
- Analysis of medication efficacy for different types of social phobia.
Main Results:
- Monoamine oxidase inhibitors (MAOIs), serotonin selective reuptake inhibitors (SSRIs), and benzodiazepines demonstrate established efficacy.
- Beta-adrenergic receptor blockers show utility for specific performance anxiety but limited benefit for generalized social phobia.
Conclusions:
- Pharmacotherapy offers effective treatment options for social phobia.
- Treatment decisions should consider the specific phobia type and co-occurring psychiatric conditions.